Details for Patent: 6,770,262
✉ Email this page to a colleague
Summary for Patent: 6,770,262
Title: | Nasal administration of agents for the treatment of gastroparesis |
Abstract: | The present invention is directed to a method for the treatment of gastroparesis by the use of metoclopramide nasal formulation. |
Inventor(s): | Lehman; Laura S. (Palo Alto, CA), Tierney; David (Shrewsbury, NJ), Retzios; Anastassios D. (San Ramon, CA), Petrone; Michael (Voorhees, NJ), Young; David (Ellicott City, MD), Trapnell; Carol B. (Ellicott City, MD), Oliver; Ruth (Maidenhead, GB) |
Assignee: | Questcor Pharmaceuticals, Inc. (Union City, CA) |
Application Number: | 09/821,139 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 6,770,262
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,770,262
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 466569 | ⤷ Sign Up | |||
Australia | 4968401 | ⤷ Sign Up | |||
Canada | 2403994 | ⤷ Sign Up | |||
Cyprus | 1111396 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |